Co Inc

• Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms - Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.
• Wall Street braced for a private credit meltdown. The risk of one is rising - Private credit is expected to grow from $3.4 trillion in 2025 to an estimated $4.9 trillion by 2029. Wall Street is starting to raise alarms about the risks.
• Nine of the largest pharma companies ink deals with Trump to lower drug prices - President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than overseas.